GREM1 and gastric cancer: Survival analysis for GREM1, BAG2, TRIP6, OLFM4 and MAGE-A9 mRNA expression from the TCGA dataset from patients with the diffuse or intestinal subtypes of gastric cancer did not show any statistically significant difference.